Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WHO Clears Rabies Vaccine Of India’s Zydus Cadila

This article was originally published in PharmAsia News

Executive Summary

The World Health Organization has cleared India's Zydus Cadila to sell its Lyssavac rabies vaccine to United Nations agencies. The clearance makes Zydus, part of Zydus Cadila Group, the first Indian company approved for UN sales. Zydus markets the vaccine, produced in collaboration with Berna Biotech of Switzerland, in India as Vaxirab. Outside of India, the vaccine is available only in South Asia and Africa. (Click here for more
Advertisement
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066899

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel